We, therefore, believe that this model can potentially be useful to understand the influence of MSX1 overexpression on pulmonary vasculature that can cause or lead to increase in pulmonary pressure, and thus help understand the early events that occur in PAH prior to detectable clinical features, such as increase in RVSP. The gene discussed is MSX1; the disease is pulmonary arterial hypertension.